{"id":"W2763770203","doi":"10.1093/annonc/mdx440.040","title":"Pembrolizumab (pembro) vs standard of care (SOC) for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 3 KEYNOTE-040 trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Population; Cetuximab; Internal medicine; Oncology; Head and neck cancer; Radiation therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003762116,0.0002386009,0.001691936,0.0001196041,0.0002186309,0.00001138539,0.000179294,0.0001369655,0.00005748014],"category_scores_gemma":[0.0008686383,0.0001815184,0.0002430577,0.00005523526,0.000361274,0.00007660501,0.0001077925,0.000164803,0.00000154566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007439494,"about_ca_system_score_gemma":0.0009355859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001832638,"about_ca_topic_score_gemma":0.0007253683,"domain_scores_codex":[0.9982027,0.0001004373,0.0006647694,0.000359483,0.0002517258,0.0004209221],"domain_scores_gemma":[0.9976228,0.0004422094,0.0005777262,0.0004969945,0.0006636559,0.0001965424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7877594,0.001707469,0.0008737191,0.00311669,0.0001961252,0.0001198279,0.004428918,8.319732e-7,0.0007738924,0.0001187476,0.02276041,0.178144],"study_design_scores_gemma":[0.4117429,0.3899447,0.003527322,0.0002664085,0.0007874247,0.00004290987,0.001471436,0.00005723905,0.02690529,0.0001853169,0.1647521,0.0003169822],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836605,0.006502333,0.00003348604,0.003594348,0.0006422551,0.001614699,0.00053064,0.00001490093,0.003406876],"genre_scores_gemma":[0.9968424,0.001036372,0.00109164,0.000326083,0.0002608957,0.000131498,0.00002860963,0.00002799409,0.0002544385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3882372,"threshold_uncertainty_score":0.7402104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1544250429091509,"score_gpt":0.4638174625534254,"score_spread":0.3093924196442746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}